1 year agoCytokinetics Breakthrough Sends Stocks Skyrocketing || Short NewsEntertainment World and Celebs
1 year agoDr. David Martin Puts Biopharmaceutical Complex on Notice: “No More Gain-of-Function Research — Period”Vigilant News NetworkVerified
3 years agoDONALD TRUMP IS NOTHING MORE THAN A VAX SALESMAN PUSHING THE VAX STOCK PRICES UP - EITHER HE IS VERY UN-INFORMED? OR HE JUST CARES ABOUT THE VAX STOCK PRICES? WHAT DO YOU THINK? #FOLLOWTHEMONEYnonvaxer420
7 months agoAZTR Stock - AZITRA 600% - SCALP - TOP gainers LOW float! - Martyn Lucas InvestorMartyn Lucas InvestorVerified
2 months agoNuocheng Jianhua Nanjing R&D Center was awarded the title of "Specialized, Refined, Unique and New"DTnewswire
2 years agoProvention Bio Announces $125 Million Term Loan Facility with Hercules CapitalTrialSiteNews
1 year ago'It's a Crime': Pfizer Knew of 1223 Post-Vax Deaths Just in the First 90 DaysVigilant News NetworkVerified
1 year agoDebunking Covid Animal Myths & Theories | Dr. Steven Quay & Maryam HeneinMaryamXHeneinVerified
2 years agoCoronavac approved for emergency use in 18-59 age group in SAIOL-IndependentOnlineVerified
1 year agoDr. McCullough: There Was Plan to Promote Fear & Death to Make Way for Mass VaccinationRaisingAwareness
3 years agoCOVID-19 vaccine for 5- to 11-year-olds is safe and shows 'robust' antibody response, Pfizer saysWXYZVerified
2 years agoC Difficile treatment. Canadian phase 2 clinical trial, recruiting patients.Canadian phase 2 clinical trial, recruiting patients.